FDA Approves IDKIT HP ONE — Meridian Bioscience Israel Ltd

Meridian Bioscience Israel Ltd FDA-approved NDA021314 for the oral administration of IDKIT HP ONE, a diagnostic test integrating citric acid anhydrous and 13C-urea to evaluate *Helicobacter pylori*. This 13C urea breath test facilitates non-invasive gastroenterological screenings, with the introduction of IDKIT HP ONE positioning the firm to address material demand in the preventive healthcare diagnostics market.